Cargando…
Epidemiology, mortality and effectiveness of prophylaxis for Pneumocystis jiroveci pneumonia among rheumatic patients: a territory-wide study
BACKGROUND: Pneumocystis jiroveci pneumonia (PJP) is an opportunistic infection affecting immunocompromised individuals. However, evidence regarding the burden and effectiveness of prophylaxis among rheumatic patients remains limited. Delineating the epidemiology and efficacy of prophylaxis among rh...
Autores principales: | Chan, Shirley Chiu Wai, Chung, Ho Yin, Lau, Chak Sing, Li, Philip Hei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582139/ https://www.ncbi.nlm.nih.gov/pubmed/34763703 http://dx.doi.org/10.1186/s12941-021-00483-2 |
Ejemplares similares
-
Pneumocystis jiroveci Pneumonia
por: Haque, Abida K., et al.
Publicado: (2008) -
1024. Evaluation of Atovaquone Prescribing for Pneumocystis jiroveci Pneumonia (PJP) Prophylaxis
por: Aleissa, Muneerah, et al.
Publicado: (2019) -
The Pathogenesis and Diagnosis of Pneumocystis jiroveci Pneumonia
por: Apostolopoulou, Anna, et al.
Publicado: (2022) -
336. COVID-19 and Pneumocystis jiroveci Pneumonia
por: Saling, Christopher, et al.
Publicado: (2021) -
The cytological diagnosis of Pneumocystis jiroveci pneumonia in bronchoalveolar lavage
por: Kapatia, Gargi, et al.
Publicado: (2023)